Skip to content
Cold-chain shipping · Ships from Canada · Research use only
Neural

PE-22-28 Peptide in Canada

PE-22-28 is a lab-made peptide of seven amino acids (protein building blocks), a piece of spadin. Spadin itself comes from a protein called sortilin. Scientists study PE-22-28 as a blocker of TREK-1, a channel that lets potassium out of nerve cells. All the research behind it is one 2017 paper from one lab. It has had no human trials.

PE-22-28 peptide 5mg vial, Pro Peptide
$69.77CAD per vial

Pack prices and discount codes don't combine. You always get the bigger saving.

Strength5mg
1

Sold for laboratory research use only. Not for human or veterinary use. 19+.

Amino acids, sequence GVSWGLR
7
Molar mass
773.9g/mol
One 2017 paper, no independent replication
1 lab
Human trials, registered or published
0
Approved as a drug
Nowhere

What is PE-22-28?

The plain-language version, first.

A seven-residue fragment aimed at a channel most people have never heard of.

Your brain runs on doors.

Not metaphorically. Ion channels are literal openings that let charged particles through a membrane, and almost everything a neuron does depends on which ones are open.

TREK-1 is one of those doors. PE-22-28 is seven amino acids studied for closing it.

That is an unusually specific thing to be aimed at, and specificity is generally a good sign in a research compound. Vague mechanisms are where nonsense lives.

The fragment comes from a larger protein, which is a common origin story on this shelf and usually the most interesting part.

Seven residues, one named channel, and a very short list of people who have looked at it.

What is PE-22-28?

What researchers watch it do.

Channels are doors. This one is studied for closing a specific door.

Alright, doors. Say a room has a door that is normally propped open, and propping it open is what keeps the room quiet.

Close the door and the room behaves differently. Not because you added anything. Because you changed what could leave.

That is roughly the logic of a channel blocker, and it is why channel work is some of the cleanest pharmacology going.

TREK-1 is a potassium channel, and potassium leaving a cell is one of the main ways a neuron settles back down after firing. Change that and you change excitability.

So the proposed mechanism is coherent, it is specific, and it is testable. All three are genuinely good marks.

Here's the honest part. Coherent and testable is not the same as tested.

A mechanism that makes sense on paper is where research starts. It is not where it finishes, and this one has not finished.

What does the research say about PE-22-28?

What the studies found, and where they stand.

One lab. One paper. That is not a criticism, it is the whole file.

This is the shortest file in the catalogue and we are going to be plain about why that matters.

One laboratory. One paper. No independent group has published a replication.

A striking result from a single source is not the same kind of object as a modest result from four.

That is not an accusation about anybody's work. Single-source findings are how most science begins, and plenty of them hold up perfectly well when somebody else looks.

But plenty do not, and there is no way to know which this is until somebody looks. Nobody has yet.

No human trials. Nothing approved. One group, one publication, and a compound with a genuinely interesting target attached to it.

The correct posture here is curiosity with the brakes on, and anybody selling it with more confidence than that is filling in a blank that is still blank.

PE-22-28 peptide, research grade, sold for laboratory use only.

What did the lab find in our PE-22-28?

The lab's numbers for the lot on the shelf.

98.72%HPLC purity
Lot 2202-152
LaboratoryJanoshik Analytical
TestedFebruary 2026
MethodHPLC + mass spectrometry
Size5 mg, freeze-dried powder
Stored atKeep it cold and out of the light
Reported resultsas reported by the laboratory
HPLC purity
98.72%
Identity
Confirmed
Measured content
label 5 mg4.91 mg

See the lab results page

What's in a vial of PE-22-28?

The chemistry, exactly as released.

Handling
FormatFreeze-dried powder
StorageKeep it cold and out of the light
ReconstitutionBacteriostatic water
Work out the drawPeptide calculatorLab resultsLot 2202-152

Who studies PE-22-28?

Who tends to order this one, and why.

  1. 1

    Ion channel pharmacologists

    TREK-1 is a two-pore domain potassium channel with a well characterised knockout phenotype, and PE-22-28 is the most potent reported peptide blocker of it.

  2. 2

    Peptide degradation and stability groups

    The discovery method is the transferable part. Screening serum degradation fragments rather than engineering around them is a strategy that generalises well past this compound.

  3. 3

    Behavioural neuroscience labs

    Forced swim and novelty-suppressed feeding readouts were both reported, the latter after four days, which puts it in the sub-chronic range.

  4. 4

    Anyone weighing a single-source result

    PE-22-28 is a clean case study in how to handle a spectacular number that has not been independently replicated.

Sold for laboratory research only. This is not guidance for personal use, and nothing here is a recommendation.

Where did PE-22-28 come from?

How it got here.

Sortilin is a sorting receptor, and like a lot of receptors it gets built with a propeptide stuck on the front that has to come off before the receptor works. Nobody expected an antidepressant lead to fall out of that.

Spadin came first, described in 2010 as an endogenous blocker of TREK-1. Interesting molecule, real behavioural data in lab models, and one very ordinary flaw. Serum chewed it up.

Seven years later the same institute in Valbonne did something a little bit backwards. Rather than trying to protect spadin from serum, they let serum have it and then went looking through what was left.

The fragment that came out blocked the channel several hundred times better than the parent did.

There's a general lesson in there that goes past this one compound. Degradation products get written off as waste, and sometimes they're the answer. It just requires being willing to run the HPLC on the wreckage.

  1. 1

    Sortilin's propeptide

    PE-22-28 corresponds to residues 22 to 28 of the sortilin propeptide (UniProt Q99523), which is also where spadin originates.

  2. 2

    Spadin, 2010

    Described in PLoS Biology as an endogenous TREK-1 blocker with antidepressant activity in lab models, with serum instability as its practical limitation.

  3. 3

    Reading the wreckage, 2017

    The Valbonne group let serum degrade spadin, then identified and screened the fragments. The shortest useful piece turned out to be the most potent.

How do I buy PE-22-28 in Canada?

What ships, how fast, and the paperwork.

Research use only. Sold for laboratory research use only, not for human or veterinary consumption. Health Canada's advisory of 9 April 2026 states that peptides are generally regulated as prescription drugs in Canada, and that "For Research Use Only" labelling does not make these products legal. PE-22-28 is not named in that advisory, which is not the same as being permitted.

One lab, one paper. The quantitative case for this compound, including the 0.12 nanomolar IC50, traces to a single 2017 report from one research group. We could not find independent replication, and that is the most important thing to know before comparing it to anything else.

Sport testing. PE-22-28 is not named on the WADA Prohibited List. It is caught by S0, which covers substances not approved by any government health authority for human therapeutic use.

What else do people ask?

5 answers, none of them dodges.

How was PE-22-28 discovered?

By letting blood destroy something else and reading the results. Researchers at the CNRS institute in Valbonne incubated spadin with serum, separated the degradation fragments by HPLC, identified them by mass spectrometry, and screened the shortened peptides for TREK-1 blockade (Djillani, 2017, PMID 28955242). PE 22-28 was one of those fragments. It's a genuinely clever inversion of how peptide instability is usually handled.

Is PE-22-28 really more potent than spadin?

That's what the source reports, and the margin is large. PE-22-28 is given at an IC50 of 0.12 nanomolar against TREK-1, compared with 40 to 60 nanomolar for spadin, which works out to roughly three hundred to five hundred fold. Truncating a peptide usually costs potency rather than multiplying it, so this is an unusual result and it rests on one paper.

What is TREK-1 and why does it matter here?

TREK-1 is a two-pore domain potassium channel that has been implicated in depression, most notably because lab models engineered without it show a depression resistant phenotype. That finding is what made blocking the channel an attractive pharmacological idea, and spadin was described as an endogenous blocker of it in PLoS Biology in 2010. PE-22-28 blocks the same channel.

Where does the name PE-22-28 come from?

It's a coordinate rather than a brand. Sortilin is made with a propeptide attached that gets removed during maturation, and that propeptide is UniProt Q99523. This peptide corresponds to residues 22 through 28 of it. Spadin comes from the same propeptide, so the lineage runs sortilin propeptide, then spadin, then PE-22-28, getting shorter at each step.

Are there human studies of PE-22-28?

None. No registered trials, no published human data. Everything reported is lab work, specifically the forced swim test, novelty-suppressed feeding after four days, and induced neurogenesis, all from the 2017 paper. The gap between a picomolar in vitro number and any human outcome is the entire drug development process, and none of it has happened here.

PE-22-28 Peptide vs Selank: what's the difference?

Stacked together constantly, compared almost never.

Two neuro peptides with two different kinds of thin file, and the difference between the kinds is worth understanding.

PE-22-28 Peptide

PE-22-28 has one laboratory and one paper. Nobody has replicated it, and nobody has contradicted it either. Its file is small because almost nobody has looked.

Thin by youth. One source, unreplicated.
Selank

Selank has decades of Russian clinical use and registration, with a literature run largely without placebo controls. Its file is large and methodologically hollow in the middle.

Thick by volume, thin by design.

One compound needs more eyes and the other needed better experiments. Neither problem fixes itself, and confusing the two kinds of thin is how bad buying decisions get made. Selank has its own page here

What pairs well with PE-22-28?

What researchers stack alongside it.

Pairing is where research gets ahead of itself. These are the compounds researchers put in the same order as PE-22-28 Peptide, which is a statement about ordering habits, not about evidence. Two things in one cart have not been studied together unless somebody studied them together.

NeuralSemax Peptide
$39.77
CAD

A tiny lab-made protein built in Moscow from one chopped-off piece of a stress hormone, and sold in Russian pharmacies as nose drops. Scientists study it on stroke and on BDNF, which is basically plant food for your nerve cells.

1
In stock · ships same-day with ice pack
NeuralSelank Peptide

A seven-building-block peptide from Moscow, made from a tiny immune protein with a sturdy tail added so it lasts longer. Scientists there study it on anxiety, which makes it the calm roommate of Semax, built at the same institute.

1
In stock · ships same-day with ice pack

Supplies for the lab

SuppliesBacteriostatic Water

The water every freeze-dried vial needs, and the one item everybody forgets. Sterile water with a preservative, so one vial lasts more than one draw.

1
In stock · ships same-day with ice pack

What else is in Neural?

Other compounds in the same research category.

See all 8 in Neural →

Ready to order PE-22-28?

One last look before you decide.

Freeze-dried, lab results on the page, ships cold

You've got the file and the lab's numbers that back it, lot by lot. If that's the kind of source you were after, PE-22-28 is right here.

For research use only

Sold for laboratory research use only. Not for human or veterinary use, and not for human consumption. 19+. Not approved by Health Canada or any other regulatory body.

Page last updated November 12, 2026. Reviewed by the Pro Peptide team.

What do people search for with PE-22-28?

Related searches.